Fevertree reports 7% revenue and 9% adjusted EBITDA growth
Fevertree said revenue rose 7% year-on-year, with strong US and UK performance and portfolio diversification driving growth. Adjusted EBITDA increased 9%, supporting a £60m share buyback and higher dividend.